Remove 2023 Remove Electronics Remove Individual Remove Management
article thumbnail

Patient and Caregiver Use of Patient Portal Features [Survey research or cross-sectional study]

Annals of Family Medicine

Context: Patient portals (PPs) are online healthcare platforms enabling patients access their electronic health records and offering different features to help patients manage their care such as viewing and entering health information, and permitting asynchronous communication between patients and their providers.

Patients 130
article thumbnail

Episode 293 – Antiracism in Medicine Series – Episode 22 – Live from SGIM 2023: Best of Antiracism Research at the Society of General Internal Medicine’s 2023 Annual Meeting

The Clinical Problem Solvers

[link] CPSolvers: Anti-Racism in Medicine Series Episode 22 – Live from SGIM 2023: Best of Antiracism Research at the Society of General Internal Medicine’s 2023 Annual Meeting Show Notes by Alec J. Identify strategies to mitigate bias and stigma in the electronic health record as a trainee and medical practitioner.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI-Drive Targeted Qualitative Analysis: A Useful New Method for Primary Care Research [Qualitative research]

Annals of Family Medicine

This analysis was part of a larger implementation study called PATHWEIGH, which provides a toolset embedded in the EpicTM electronic health record and other supportive services to help practices provide weight management to their patients. We utilized AI tools in the qualitative software program Atlas.ti

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). Pharmacists’ Corresponding Responsibility A controlled substance prescription, to be valid, must be issued for “a legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” Complaint ¶ 58. Complaint ¶ 59.

article thumbnail

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

Section 3606(a) of the Food and Drug Omnibus Reform Act (FDORA) directed FDA to “issue or revise draft guidance that includes recommendations to clarify and advance the use of decentralized clinical studies to support the development of drugs and devices,” not later than December 29, 2023. DHTs include monitoring instruments (e.g.,

Clinic 59
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. However, we do not guarantee individual replies due to the high volume of messages. The initiative aims to attract additional private investment and facilitate FDA approval.

article thumbnail

Sweet! A Metabolic Disorders focused podcast episode

PEMBlog

This episode will help you better prepare for and manage children with inborn errors of metabolism in the Emergency Department. Updated 2023 Jul 17]. As always, I’m your host, Brad Sobolewski, and this episode focuses on the management of children with metabolic disorders who present to the emergency department.